Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

Author： Home P.  

Publisher： Springer Publishing Company

ISSN： 0012-186X

Source： Diabetologia, Vol.50, Iss.7, 2007-07, pp. : 1561-1562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Response to comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

By Nauck M.   Trautman M.   Brodows R.   Johns D.   Northrup J.   Kim D.  

Diabetologia, Vol. 50, Iss. 7, 2007-07 ,pp. : 1563-1564

Springer Publishing Company

Access to resources Recommend Favorite

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

By Nauck M.   Duran S.   Kim D.   Johns D.   Northrup J.   Festa A.   Brodows R.   Trautmann M.  

Diabetologia, Vol. 50, Iss. 2, 2007-02 ,pp. : 259-267

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Johnson J.   Simpson S.   Eurich D.   Majumdar S.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2805-2806

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Tayek J.  

Diabetologia, Vol. 49, Iss. 11, 2006-11 ,pp. : 2807-2808

Springer Publishing Company

Access to resources Recommend Favorite

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930–936

By Raccah D.  

Diabetologia, Vol. 50, Iss. 5, 2007-05 ,pp. : 1109-1110

Springer Publishing Company

Access to resources Recommend Favorite